SAN FRANCISCO, Oct. 17 – Applied Biosytems and SurroMed jointly received a three-year $8 million grant from the National Institute of Standards and Technology Advanced Technology Program, the companies announced Wednesday.
The grant is for the development of Mountain View, Calif.-based SurroMed's nanoscale technology and Foster City, Calif.-based Applied Biosystems' multiplexing chemistry capabilities for DNA analysis. $3.7 million is slated for SurroMed and $4.3 million for Applied Biosystems, according to the companies.
“We are pleased to receive the NIST-ATP grant to develop our novel technology with the chemistry development capabilities of Applied Biosystems,” Gordon Ringold, CEO of SurroMed, said in a statement. “We are developing the technology for use in our discovery programs, and the collaboration with Applied Biosystems reflects our strategy to partner certain applications with leading companies.”
Applied Biosytems is a unit of Applera.